Skip to content
Screener

Prestige Consumer Healthcare PBH EPS (Diluted)

EPS (Diluted) at other companies

Procter & Gamble logo
Procter & GamblePG
$6.62+347%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.27-0.9%
Perrigo Company logo
Perrigo CompanyPRGO
$0.53+983%
HRO
HarrowHROW
-$0.74-48.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$3.82-2,287%
Cencora logo
CencoraCOR
$3.94+11.9%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands, except per share data)Three Months Ended June 30, 20262025
Net income$29,177$47,466
Earnings per share:
Basic$0.61$0.96
Diluted$0.61$0.95
Weighted average shares outstanding:
Basic47,46249,475
Diluted47,60449,833
Comprehensive income, net of tax:

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's EPS (diluted)?
Prestige Consumer Healthcare (PBH) reported EPS (diluted) of $0.61 in Q2 2026.
How has Prestige Consumer Healthcare's EPS (diluted) changed year-over-year?
Prestige Consumer Healthcare's EPS (diluted) decreased by 35.8% year-over-year, from $0.95 to $0.61.
What is the long-term trend for Prestige Consumer Healthcare's EPS (diluted)?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's EPS (diluted) has grown at a -0.8% compound annual growth rate (CAGR), from $4.04 to $3.91.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Prestige Consumer Healthcare's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude